What We're Reading: Page 345
Industry reads hand-picked by our editors
Mar 28, 2016
-
Stat
Google’s bold bid to transform medicine hits turbulence under a divisive CEO
-
Marketing Dive
A ban on drug ads would hit magazine and TV most
-
Science 2.0
Antipsychotic Drugs Linked To Increased Mortality Among Parkinson's Disease Patients
-
The Korea Herald
Celltrion close to finalizing European sales partners for new biosimilars
Mar 24, 2016
Mar 23, 2016
Mar 22, 2016
Mar 21, 2016
-
Inc.com
What This Guy Learned From Doing Martin Shkreli's PR
-
STAT
Avoiding ‘teapot tempest,’ Clinton campaign distances itself from Theranos
-
Washington Post
A window into one of the most baffling things about drug prices
-
Tech Crunch
YC-backed Perlstein Lab continues their rare disease drug discovery
Mar 18, 2016
Mar 17, 2016
-
ProPublica
Now There’s Proof: Docs Who Get Company Cash Tend to Prescribe More Brand-Name Meds
-
Forbes
Five Lessons Big Pharma Should Learn From Valeant's Collapse
-
FierceBiotech
GSK adds Miltenyi Biotec to its oncology shopping CAR-T as Witty checks out
-
STAT
1 in 3 Americans blame doctors for national opioid epidemic, STAT-Harvard poll finds
Previous
